Table 27, Median treatment ranks and probability of being the best treatment for all interventions for mean blood loss, caesarean birth subgroup - Evidence reviews for uterotonics for the prevention of postpartum haemorrhage - NCBI Bookshelf

Warning: The NCBI web site requires JavaScript to function. more...

Table 27Median treatment ranks and probability of being the best treatment for all interventions for mean blood loss, caesarean birth subgroup

Intervention	Median (95% CrI) treatment rank	Probability of being best
Misoprostol plus oxytocin	2 (1, 6)	28.40%
Carbetocin	4 (1, 7)	2.76%
Oxytocin unspecified dose	3 (1, 11)	30.46%
Ergometrine plus oxytocin	4 (1, 9)	4.88%
Misoprostol >600 mcg and ≤ 800 mcg	4 (1, 11)	24.50%
Misoprostol ≤ 600 mcg	6 (3, 10)	0.23%
Oxytocin > 10 IU	7 (4, 10)	0.00%
Oxytocin >1 IU and ≤ 5 IU	8 (4, 11)	0.12%
Ergometrine	10 (1, 12)	2.85%
Oxytocin >5 IU and ≤ 10 IU	9 (6, 12)	0.00%
Placebo	11 (1, 12)	5.20%
Oxytocin ≤1 IU	11 (3, 12)	0.60%

From: Evidence reviews for uterotonics for the prevention of postpartum haemorrhage

Cover of Evidence reviews for uterotonics for the prevention of postpartum haemorrhage

Evidence reviews for uterotonics for the prevention of postpartum haemorrhage: Intrapartum care: Evidence review M.

NICE Guideline, No. 235.

London: National Institute for Health and Care Excellence (NICE); 2023 Sep.

Copyright © NICE 2023.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.